Fauci perfect record intact.
— Phil Kerpen (@kerpen) July 15, 2021
"Routine use of remdesivir may be associated with increased use of hospital beds while not being associated with improvements in survival."https://t.co/WcPZ2RO6QV
by Daniel Horowitz for The Blaze, reposted at the Ron Paul Institute
Sixteen months into this virus, our
government has nothing to offer us in terms of treatment in the hospital but
remdesivir at $3,100 a dose and zero treatment options at the critical
early-stage, when serious complications can be pre-empted. Now, a new study
from the University of Iowa shows what we knew all along – that remdesivir
failed to reduce mortality one iota. Why are we to believe the same government
entities about embracing the clot shots and shunning so many other cheaper and
effective treatments after spending billions and losing countless lives on a
failed drug?
After 62 studies, 32 of them randomized controlled trials,
establishing ivermectin as an effective treatment and an even more effective
preventative to keep people out of the hospital in the first place, our
government refuses to endorse its use and Big Tech continues to censor it. They claim they need more studies. Yet
not a single randomized controlled trial showed remdesivir to be effective
before they dove in headfirst and the NIH made it the only approved antiviral
treatment for COVID. Now, a University of Iowa study published in JAMA Network Open on Thursday has shown
that remdesivir was a complete bust.
Among the 2,334 US veterans studied in 124
hospitals, a higher share of remdesivir patients (12.2 percent) who took part
in the study died than patients in the control group (10.6 percent). Moreover,
on average, remdesivir patients spent six days in the hospital, while control
group patients spent only three.
Previously, last October, the World Health
Organization found that use of remdesivir in 11,000 patients
across 400 hospitals in the world failed to lower the mortality rate or
truncate time of stay in the hospital.
Take a look at this chart of
treatment protocols for COVID hospital patients from the NIH, and you will see that aside from remdesivir, the
only other treatment they offer is dexamethasone as the corticosteroid of
choice to treat inflammation.
Again, dexamethasone was approved after just one randomized
controlled trial last year, when ivermectin had over two dozen. This new
study from the University of Iowa seems to show that dexamethasone is also a
bust because outcomes did not improve among those who received that steroid
along with remdesivir, as opposed to the control group that did not. In other
words, after 16 months of research by doctors on numerous helpful antiviral and
anti-inflammatory drugs, as well as more effective corticosteroids, the
government has ensured that we have not advanced one iota in treating this
virus. This is truly criminal and probably the gravest scandal of COVID.
Contrast this to ivermectin, which is available
for $25. A Cochrane-standard (the highest level review) meta-analysis of
ivermectin against COVID-19 by Bryant-Lawrie, which has been published in the American Journal
of Therapeutics, concluded that ivermectin reduced fatality in hospitalized
patients by 62%. But more important is getting people to use this immediately
in an outpatient setting and, for vulnerable people, even preventively. The
study found that "ivermectin prophylaxis reduced covid-19 infection by an
average 86%."
Fair use excerpt. Read the whole article here.
